Maxim Group will underwrite the IPO and have a 45-day option to purchase up to an additional 900,000 shares over and above the 6 million being offered to cover over allotments. The company applied to ...

Rocket plans to revolutionize space propulsion and launch through its next-generation rocket engines and launch systems that are scalable reusable, and more cost-effectiveiRocket and BPGC, a special ...

TON Foundation is teaming up with Kingsway Capital to launch a Toncoin treasury company, raising $400 million to acquire TON.

Special purpose acquisition companies (SPACs) offer a unique way for companies to go public. A SPAC is a shell company listed on a stock exchange that aims to acquire a private company, allowing ...

The company has $518 million to spend from its IPO, likely on a software or fintech company. TPG Pace Tech has $450 million in a hunt for tech companies while TPG Pace Beneficial Finance has $350 ...

The special purpose acquisition company market isn’t dead yet, apparently. SoftBank Group-backed digital lender Better.com plans to make its public debut in the fourth quarter of 2021 via SPAC, ...

Last week, a stockholder in three special purpose acquisition companies (“SPACs” – Pershing Square Tontine Holdings, Ltd. (“PSTH”), GO Acquisition Corp. and E.Merge Technology ...

Perhaps you’ve heard of SPACS, or special-purpose acquisition companies, as an alternative to IPOs. They are, in some respects, easier than IPOs — but there are pitfalls for investors, too.

Because it sure wasn't for investors, who snubbed GrabAGun when it opened for public trading on the NYSE Wednesday morning.

Legendary Entertainment is eyeing a deal to acquire Lionsgate Studios, following the latter company’s separation from Starz, Variety has confirmed. The status of the two companies’ deal talks could ...

DARIEN, CONNECTICUT / ACCESS Newswire / July 17, 2025 / Solarius Capital Acquisition Corp. (NASDAQ:SOCAU) (the "Company") today announced the closing of its initial public offering of 17,250,000 units ...

Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. in a deal worth $2.5 ...